Joseph S. McCracken

Insider Reports History

Entity
Individual
Location
C/O Nexvet Biopharma Plc, Natl Inst, Fosters Avenue, Mount Merrion, Blackrock, Ireland
Signature
/s/ Ryan Trytten, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph S. McCracken:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Savara Inc Director Common Stock 191K $849K $4.45 Dec 14, 2023 Direct
Savara Inc Director Stock Option (Right to Buy) 40K Dec 13, 2022 Direct
LUMOS PHARMA, INC. Director Stock Option (Right to Buy) 3.33K Jun 5, 2024 Direct
Kindred Biosciences, Inc. Director Stock Option (right to buy) 0 $4.81 Aug 27, 2021 Direct

Insider Reports Filed by Joseph S. McCracken

Symbol Company Period Transactions Value $ Form Type Date Filed Role
(LUMO) LUMOS PHARMA, INC. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
SVRA Savara Inc Dec 14, 2023 1 $0 4 Dec 15, 2023 Director
LUMO LUMOS PHARMA, INC. May 10, 2023 1 $0 4 May 12, 2023 Director
SVRA Savara Inc Dec 13, 2022 1 $0 4 Dec 15, 2022 Director
LUMO LUMOS PHARMA, INC. Nov 16, 2022 1 $20.1K 4 Nov 18, 2022 Director
LUMO LUMOS PHARMA, INC. Aug 25, 2022 1 $27.3K 4 Aug 26, 2022 Director
LUMO LUMOS PHARMA, INC. May 5, 2022 1 $0 4 May 9, 2022 Director
SVRA Savara Inc Dec 14, 2021 1 $0 4 Dec 14, 2021 Director
KIN Kindred Biosciences, Inc. Aug 27, 2021 5 -$233K 4 Aug 30, 2021 Director
LUMO LUMOS PHARMA, INC. Aug 11, 2021 1 $56.4K 4 Aug 13, 2021 Director
LUMO LUMOS PHARMA, INC. May 20, 2021 2 $0 4 May 24, 2021 Director